Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998049322) NEUROTRYPSIN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/049322 International Application No.: PCT/IB1998/000625
Publication Date: 05.11.1998 International Filing Date: 24.04.1998
Chapter 2 Demand Filed: 19.11.1998
IPC:
A61K 38/00 (2006.01) ,A61K 48/00 (2006.01) ,C12N 9/64 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9
Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
14
Hydrolases (3.)
48
acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)
50
Proteinases
64
derived from animal tissue, e.g. rennin
Applicants:
SONDEREGGER, Peter [CH/CH]; CH
Inventors:
SONDEREGGER, Peter; CH
Agent:
ZINK-WILD, Markus, Peter; Patentanwaltsbüro Zink Birchlistrasse 11 CH-8173 Riedt-Neerach, CH
Priority Data:
966/9726.04.1997CH
Title (EN) NEUROTRYPSIN
(FR) NEUROTRYPSINE
Abstract:
(EN) There are described neurotrypsins of the formulas (I) or (II), including the separate coding and coded sequences of these compounds of the formulas (I) or (II). These compounds may be used as at least one active compound in a pharmaceutical component. The coded peptide sequences of these compounds may be used as targets for the development of pharmaceutical drugs.
(FR) Cette invention concerne des neurotrypsines correspondant aux formules (I) ou (II), ainsi que les séquences codées et de codage distinctes des composés correspondant auxdites formules. Ces composés peuvent utilisés en qualité d'un ou de plusieurs composés actifs dans un composant pharmaceutique. Les séquences de peptide codées de ces composés peuvent être utilisées comme cibles servant à l'élaboration de produits pharmaceutiques.
Designated States: AL, AU, BA, BB, BG, BR, CA, CN, CU, CZ, EE, GE, GW, HU, ID, IL, IS, JP, KP, KR, LC, LK, LR, LT, LV, MG, MK, MN, MX, NO, NZ, PL, RO, RU, SG, SI, SK, SL, TR, TT, UA, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0977871US20050032694US20080295186DE000069831737AU1998068491DK0977871
PT977871